What Should Doctors Know About FDA’s Black Box Change for Hormone Replacement Therapy Drugs? - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

What Should Doctors Know About FDA’s Black Box Change for Hormone Replacement Therapy Drugs?

A Keck Medicine of USC breast surgeon discusses the FDA’s decision — and whether using HRT to treat menopause symptoms actually affects breast cancer risk.

  • January 28, 2026

  • 8 min

Share

Original Source(s)

What Should Doctors Know About FDA’s Black Box Change for Hormone Replacement Therapy Drugs?

  • January 28, 2026

Related Content

Endovascular resuscitation: an expert practice review

Correction: Sjögren’s syndrome–associated fulminant myocarditis presenting as cardiogenic shock requiring VA-ECMO: a case report

FDA updates PAH label with trial data

In adults diagnosed with pulmonary arterial hypertension within the previous year, adding sotatercept to background therapy reduced the risk of clinical worsening events by 76% compared with placebo.